Advertisement
Screener

Century Therapeutics, Inc. (IPSC) Company Profile

2.8 / 5 stars · 68/120 Roast Me

Available history
No dated observations
Data captured

IPO Date coverage

IPSC IPO Date summary

Century Therapeutics, Inc. (IPSC). What the retained company guidance contains and how many periods can be scored.

  • Legal name: Value Century Therapeutics, Inc..
  • Ticker: Value IPSC.
  • Exchange: Value Nasdaq.
  • IPO date: Value 21 Jun 2021.
MeasureValue
Legal nameCentury Therapeutics, Inc.
TickerIPSC
ExchangeNasdaq
IPO date21 Jun 2021
CountryUnited States
Final IPO prospectusForm 424B4 filed 2021-06-21, accession 0001104659-21-082886
Registration statementForm S-1 filed 2021-05-28, accession 0001104659-21-074278

Similar stocks

Stock NameCountryMarket CapPE Ratio
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Ocugen, Inc. (OCGN)United States$0.343B-6.34
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05